Study Stopped
Slow accrual, and revised power calculation for primary end-points
Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy
1 other identifier
interventional
52
1 country
1
Brief Summary
Cancer patients face a number of symptoms related to treatment or disease which may impair quality of life, such as decreased functional capacity, fatigue, nausea an vomiting, distress, depression and unmet psychological needs. Due to this array of symptoms, cancer patients often seek supportive complementary and alternative medicine, which many patients use along with conventional treatments. Qigong, a type traditional chinese medicine, is a mind-body exercise that combines meditation, slow physical movements, and controlled breathing. The investigators hypothesise that Qigong therapy is better in the reduction of anxiety and depression levels and the improvement of quality of life in patients with lung and gastrointestinal (GI) cancer who are eligible for anti-cancer treatment, when compared to standard exercise training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 13, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedFirst Posted
Study publicly available on registry
June 15, 2011
CompletedAugust 16, 2019
August 1, 2019
2.2 years
April 13, 2011
August 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Depression and Anxiety
Depression and anxiety will be measured using the Hospital Anxiety Depression Scale (HADS); The HADS is a 14-item self-rated questionnaire, consisting of two 7-item subscales. It was developed to identify anxiety and depression in non-psychiatric medical outpatients. Each item on the HADS is scored from 0 (no problem) to 3 (maximum distress). The HADS will be administered within 2 weeks of completing each exercise program.
6 weeks
Change in Quality of Life (QoL)
The general version of the Functional Assessment of Cancer Therapy scale (FACT-G) will be used to measure Quality of Life (QoL) after completion of each 6 week exercise program. This questionnaire consists of 4 subscales: Physical well-being (PWB), Social well-being (SWB), Emotional well-being (EWB) and Functional well-being (FWB). A change of 4 points on the total FACT score is regarded as clinically significant.
6 weeks
Secondary Outcomes (3)
Change in functional capacity
6 weeks
Change in cancer Symptoms
6 weeks
Program Satisfaction
6 weeks
Study Arms (2)
Standard Exercise
ACTIVE COMPARATORSee methods below - standard strength and endurance training
Qigong exercise
EXPERIMENTALSee methods below - medical QiGong therapy session
Interventions
The standard exercise therapy program will include 12 treatments of approximately 45 minutes duration, twice a week for a period of six weeks by the same instructor and at the same location as for Qigong therapy. This exercise program is supervised and consists of cardio-vascular and resistance training exercises. Participants are asked to refrain from practicing Qigong during this 6 week period.
Qigong therapy will be led by a trained Qigong instructor and will occur for 45 minutes sessions, twice a week for a period of six weeks. Qigong is a self-directed walking exercise program that involves arm movements that are coordinated with slight movements of the waist, while in a state of deep relaxation or meditation. Patients will be asked to refrain from independent resistance or cardiovascular training during this 6 week period.
Eligibility Criteria
You may qualify if:
- A pathologically (histological or cytological) confirmed clinical diagnosis of non-small cell lung cancer (NSCLC) or GI cancer
- Stage 3 or 4 disease and eligible for anti-cancer treatment
- Performance status (PS) of 0 - 2 as determined by the Eastern Cooperative Oncology Group-Performance Status
- Life expectancy estimated at \> 4 months
- Age 18 years or older
- Willing and able to provide informed consent
- Must be approved for participation by the oncology treatment team
- Able to communicate in French or English
You may not qualify if:
- Contraindication to exercise as determined by the oncology treatment team
- Severe cardiac or neuro-muscular/skeletal disease
- Engaging in interventions to address anxiety or depressive symptoms
- Brain metastases
- Active psychiatric conditions
- Pregnant or breast-feeding mothers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McGill Universitylead
- Jewish General Hospitalcollaborator
Study Sites (1)
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
Related Publications (1)
Vanderbyl BL, Mayer MJ, Nash C, Tran AT, Windholz T, Swanson T, Kasymjanova G, Jagoe RT. A comparison of the effects of medical Qigong and standard exercise therapy on symptoms and quality of life in patients with advanced cancer. Support Care Cancer. 2017 Jun;25(6):1749-1758. doi: 10.1007/s00520-017-3579-x. Epub 2017 Jan 19.
PMID: 28102437RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Jagoe, MD, PhD
McGill, Cancer Nutrition Rehabilitation Program
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
April 13, 2011
First Posted
June 15, 2011
Study Start
February 1, 2009
Primary Completion
May 1, 2011
Study Completion
May 1, 2011
Last Updated
August 16, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- All group data already supplied in published manuscript
- Access Criteria
- Other specific anonymized data on participants supplied for academic/research purposes by application to the senior author.
Peer-reviewed manuscripts and conference proceedings